Según un estudio, una sola dosis de un nuevo fármaco antiviral reduce a la mitad el riesgo de enfermarse de COVID grave
Related Posts
Longer School Absence After Concussion May Increase Symptom Burden
MONDAY, Jan. 23, 2023 (HealthDay News) -- Prolonged absence from school after a...
Construction Workers May Bring Toxic Metals Back Home
TUESDAY, Feb. 22, 2022 (HealthDay News) -- Construction workers may bring home...
AHA News: Bronx-Based Program Is Teaching Coding and Web Development – And Changing Lives
MONDAY, Oct. 25, 2021 (American Heart Association News) -- Nearly two years...
Pfizer to Seek FDA Approval of Boosters for Teens Ages 16-17
https://consumer.healthday.com/b-11-30-pfizer-to-s... Credit: HealthDay